The Therapeutic Goods Administration has given Pfizer's new COVID-19 jab the green light. But what about vaccines from ...

New COVID-19 strains are emerging and with it the need for updated vaccines to protect people from the virus. So how do ...

Social media users are spreading new levels of misinformation based on discredited claims that nanobots are lurking in ...

A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.

Pfizer is facing a messy showdown this week after an outside bid to revive the company’s post-Covid share plunge took an ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO ® (Respiratory Syncytial Virus Vaccine ...

Bogoch says the latest vaccine was designed for a sublineage of Omicron called KP.2, which began circulating several months ...

The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract ...

Barely three years ago, Pfizer was the toast of the pharmaceutical world and Bourla, who was elevated to the top job in 2019, wrote a book about the race to develop the coronavirus vaccine.

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practice ...

LONDON, Sept 25 (Reuters) - Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday gave Pfizer permission to take the case to the ...

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...